Lifevantage Corp (LFVN) CSO converts PRSUs, 21,801 shares withheld
Rhea-AI Filing Summary
Cunningham Kristen reported disposition transactions in this Form 4 filing.
Lifevantage Corp Chief Sales Officer Kristen Cunningham exercised performance restricted stock units, converting 43,902 PRSUs into common stock on August 31, 2025. To satisfy tax obligations, 21,801 shares were delivered at $13.10 per share. After these transactions she holds 138,706 common shares and 18,992 PRSUs directly.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider activity shows mixed transactions: PRSU conversions and an ESPP buy alongside a notable open-market sale.
The filing documents non-cash PRSU conversions totaling 43,902 units (17,752 + 26,150) that convert one-for-one into common shares, increasing share exposure without cash outlay. The ESPP purchase of 254 shares is routine employee participation. The sale of 21,801 shares at $13.10 partially offsets those increases and represents realized insider liquidity. Overall, the activity is typical compensation-related vesting plus a voluntary sale and does not by itself indicate a material change to company fundamentals.
TL;DR: Transactions appear consistent with executive compensation vesting and routine insider selling; disclosures are timely and complete.
The report identifies PRSU grants from prior years (grants dated Aug 24, 2023 and Aug 26, 2024) that vested or converted on 08/31/2025 and are disclosed as required. The presence of an ESPP purchase and a contemporaneous open-market sale suggests portfolio rebalancing or personal liquidity rather than governance concerns. The Form 4 is signed via power of attorney and includes explanatory footnotes about grant dates and one-for-one conversion, aligning with standard disclosure practice.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Performance Restricted Stock Units | 17,752 | $0.00 | $0.00 |
| Exercise | Performance Restricted Stock Units | 26,150 | $0.00 | $0.00 |
| Exercise | Common Stock | 17,752 | $0.00 | $0.00 |
| Exercise | Common Stock | 26,150 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 21,801 | $13.10 | $286K |
Footnotes (4)
- F1. On August 24, 2023, the reporting person was granted Performance Restricted Stock Units ("PRSUs") which vest upon achievement of previously established time-based and financial performance criteria.
- F2. Includes 254 total shares purchased on August 31, 2025 under the Employee Stock Purchase Plan.
- F3. On August 26, 2024, the reporting person was granted PRSUs which vest upon achievement of previously established time-based and financial performance criteria.
- F4. PRSUs convert into common stock on a one-for-one basis.
Key Figures
Key Terms
Performance Restricted Stock Units financial
Employee Stock Purchase Plan financial
tax-withholding disposition financial
one-for-one basis financial
FAQ
What transactions did Lifevantage Corp (LFVN) Chief Sales Officer Kristen Cunningham report?
How many PRSUs did Kristen Cunningham convert into Lifevantage (LFVN) common stock?
What are Kristen Cunningham’s post-transaction Lifevantage (LFVN) holdings?
How do Lifevantage (LFVN) Performance Restricted Stock Units (PRSUs) work for Kristen Cunningham?
AI-generated analysis. How Rhea-AI works. Not financial advice.